Violet Therapeutics Analysis: $11M Raised
What is Violet Therapeutics?
EphB3 inhibitors for neurodegenerative diseases
HQ Country
Cambridge, United States
Employees
1-10
Founded
2021
HQ State/Province
Massachusetts
Funding Category
Seed
HQ Full Address
Cambridge, Massachusetts 02139, United States
Product Features & Capabilities
- EphB3 small molecule inhibitor
- C-to-C Engine for cell interaction identification
